Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Corporation symbols : Uthr save search
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 10:00) - globenewswire.com
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.65%
H: 0.23%
C: -2.9%
LQDA M | $13.31 -3.62% -3.76% 830K
|
Health Technology
|
| O: 0.64%
H: 5.54%
C: 4.69%
year corporation update financial results
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024
Published: 2024-03-05 (Crawled : 12:30) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: -0.19%
H: 1.76%
C: 0.66%
conference corporation biopharma global therapeutics
United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-27 (Crawled : 12:00) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.15%
H: 2.13%
C: 1.27%
conference health corporation care therapeutics
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-21 (Crawled : 12:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -2.33%
H: 1.55%
C: 1.06%
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 2.59%
H: 3.66%
C: -0.24%
year corporation therapeutics financial results
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024
Published: 2024-02-14 (Crawled : 12:00) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: -0.29%
H: 0.72%
C: 0.61%
report year corporation therapeutics financial results market
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
Published: 2024-01-25 (Crawled : 11:00) - globenewswire.com
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.54%
H: 1.08%
C: -0.31%
LQDA M | $13.31 -3.62% -3.76% 830K
|
Health Technology
|
| O: -7.63%
H: 12.84%
C: 7.45%
drug corporation update application
Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims
Published: 2024-01-08 (Crawled : 13:30) - globenewswire.com
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: -0.61%
H: 1.34%
C: 1.33%
LQDA M | $13.31 -3.62% -3.76% 830K
|
Health Technology
|
| O: 0.79%
H: 1.41%
C: 0.78%
corporation therapeutics response
Liquidia Corporation Announces $100 Million in New Financings
Published: 2024-01-04 (Crawled : 14:30) - globenewswire.com
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: -0.04%
H: 1.06%
C: 0.89%
LQDA M | $13.31 -3.62% -3.76% 830K
|
Health Technology
|
| O: 0.88%
H: 9.33%
C: 7.03%
million corporation
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
Published: 2023-11-01 (Crawled : 11:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: -5.01%
H: 7.34%
C: 5.85%
corporation therapeutics financial results
United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023
Published: 2023-10-31 (Crawled : 11:00) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.31%
H: 0.73%
C: 0.7%
conference corporation biopharma therapeutics
United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023
Published: 2023-10-25 (Crawled : 12:30) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: -0.33%
H: 1.27%
C: -0.87%
report corporation therapeutics financial results market
United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office
Published: 2023-09-06 (Crawled : 21:00) - globenewswire.com
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.02%
H: 0.38%
C: -0.35%
LQDA M | $13.31 -3.62% -3.76% 830K
|
Health Technology
|
| O: 0.73%
H: 3.04%
C: 2.75%
patent corporation therapeutics
United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
Published: 2023-09-01 (Crawled : 12:00) - biospace.com/
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.46%
H: 0.0%
C: 0.0%
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.78%
H: 1.49%
C: 0.85%
conference corporation global therapeutics
Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-10 (Crawled : 10:00) - globenewswire.com
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.2%
H: 1.2%
C: 0.7%
LQDA M | $13.31 -3.62% -3.76% 830K
|
Health Technology
|
| O: 2.63%
H: 5.0%
C: 1.15%
corporation update financial results
United Therapeutics Corporation Reports Second Quarter 2023 Financial Results
Published: 2023-08-02 (Crawled : 12:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 7.36%
H: 0.59%
C: -7.37%
corporation therapeutics financial results
United Therapeutics Corporation to Report Second Quarter 2023 Financial Results Before the Market Opens on Wednesday, August 2, 2023
Published: 2023-07-26 (Crawled : 11:00) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.72%
report corporation therapeutics financial results market
Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America
Published: 2023-06-28 (Crawled : 10:00) - globenewswire.com
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: -0.09%
LQDA M | $13.31 -3.62% -3.76% 830K
|
Health Technology
|
| O: 0.9%
H: 10.56%
C: 10.0%
america corporation collaboration
CORRECTION -- MannKind Corporation Reports 2023 First Quarter Financial ResultsConference Call to Begin Today at 5:00 p.m. (ET)
Published: 2023-05-10 (Crawled : 09:00) - biospace.com/
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.11%
H: 1.39%
C: 1.14%
MNKD | $4.19 2.7% 2.63% 1.8M
|
Health Technology
|
| O: 5.79%
H: 14.18%
C: 9.45%
corporation financial today
CORRECTION -- MannKind Corporation Reports 2023 First Quarter Financial Results
Published: 2023-05-10 (Crawled : 00:00) - globenewswire.com
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.11%
H: 1.39%
C: 1.14%
MNKD | $4.19 2.7% 2.63% 1.8M
|
Health Technology
|
| O: 5.79%
H: 14.18%
C: 9.45%
corporation financial results
Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-04 (Crawled : 10:00) - globenewswire.com
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: -1.78%
LQDA M | $13.31 -3.62% -3.76% 830K
|
Health Technology
|
| O: 1.56%
H: 5.45%
C: 2.23%
corporation update financial results
Gainers vs Losers
| 68% | 32% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.